Symbol: |
ABRACL
|
Description: |
ABRA C-terminal like [Source:HGNC Symbol;Acc:21230]
|
Location: |
Chr6:139349819-139364439[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:246
Gene |
Compound |
Gen_sig |
Exp_pattern |
ABRACL |
NSC 704601 |
0.048 |
Down |
ABRACL |
NSC 705158 |
0.03 |
Down |
ABRACL |
NSC 707072 |
0.013 |
Down |
ABRACL |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.02 |
Down |
ABRACL |
NSC 707782 |
0.029 |
Down |
ABRACL |
NSC 708044 |
0.014 |
Down |
ABRACL |
NSC 708046 |
0.001 |
Down |
ABRACL |
2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- |
0.001 |
Down |
ABRACL |
Piperazine-2,2,5,5-tetracarbonitrile, 3,6-dipropyl- |
0.012 |
Down |
ABRACL |
NSC 708074 |
0.022 |
Down |
ABRACL |
NSC 708089 |
0.025 |
Down |
ABRACL |
NSC 708416 |
0.037 |
Down |
ABRACL |
NSC 709151 |
0.016 |
Down |
ABRACL |
Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- |
0.026 |
Down |
ABRACL |
NSC 710745 |
0.011 |
Down |
Expression pattern: Sensitivity / Resistance
Total:17 Current:13
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:7
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|